INDVIndivior Pharmaceuticals, Inc.
Health Care
Stockholders' Equity Attributable to Parent revised up 3.2% for Q3 2024
This is the 9th largest revision in INDV's history.
Stockholders' Equity Attributable to Parent·As of Dec 31, 2024
Notable restatement-$337M▲ 3.2%
was-$348M
Revised up in a 10-Q.
Verify against SEC filingsShow
As reported-$348M
Accepted 2025-03-030001625297-25-000016
Restated-$337M
Accepted 2026-10-290001628280-26-068013
StockholdersEquity · reported 8 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time INDV — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.